Metabolites called nucleotides are the building blocks of DNA and can impact cancer’s sensitivity or resistance to chemotherapy and radiation in brain cancer. Recent findings show how a specific nucleotide metabolite, called GTP, controls responses to radiation and chemotherapy in an unexpected way.